Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation - Kreuz, W; Gill, JC; Rothschild, C (Thromb Haemost, 2005)
et al.